Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.
about
Interventions for mycosis fungoidesDiagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and TargetsCutaneous primary B-cell lymphomas: from diagnosis to treatmentCutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and managementSystemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?T-cell Lymphoma Epidemiology: the Known and Unknown.T-cell lymphomas, a challenging disease: types, treatments, and future.Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.Frequency of primary cutaneous lymphoma variants in Austria: retrospective data from a dermatology referral centre between 2006 and 2013.Characteristics of Cutaneous Lymphomas in Korea According to the New WHO-EORTC Classification: Report of a Nationwide StudyThe current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indicationsTranscriptional profiles predict disease outcome in patients with cutaneous T-cell lymphomaGenetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndromeMedical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sézary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.Programmed cell death-10 enhances proliferation and protects malignant T cells from apoptosis.Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management.Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents.Romidepsin: evidence for its potential use to manage previously treated cutaneous T cell lymphoma.Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trialTreating cutaneous T-cell lymphoma with highly irregular surfaces with photon irradiation using rice as tissue compensatorRomidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphomaImmediate early response gene X-1, a potential prognostic biomarker in cancersIdentification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registriesThe Role of an Integrated Multidisciplinary Clinic in the Management of Patients with Cutaneous Lymphoma.Rapidly progressive stage IVB mycosis fungoides treated with low-dose total skin electron beam therapyResistance of Sézary cells to TNF-α-induced apoptosis is mediated in part by a loss of TNFR1 and a high level of the IER3 expressionThe Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with DoxorubicinEpigenetic biomarkers in skin cancer.Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.Novel therapeutic agents for cutaneous T-Cell lymphoma.Single-Fraction Radiotherapy for CD30(+) Lymphoproliferative Disorders.Mast Cells Are Abundant in Primary Cutaneous T-Cell Lymphomas: Results from a Computer-Aided Quantitative Immunohistological Study.Total skin electron beam therapy as palliative treatment for cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemiaAge, race, sex, stage, and incidence of cutaneous lymphomaPrimary cutaneous lymphomas: A clinical and histological study of 99 cases in Isfahan, Iran.Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genesAllogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution
P2860
Q24200749-C5406986-7101-411C-B60D-5BDF9868D393Q24629558-514C5DFA-5D01-48E8-8F57-0BD4D78BABD1Q26746551-64C03F10-DAEE-4DA4-BFAF-689E84C1A616Q26777479-D368C9BA-4777-4361-934E-72A22000663BQ27024076-97C34D31-40FE-4C31-B67D-0E2C58B52FFBQ30239965-04F38E09-AD4F-4B56-B69A-47A125E4DA32Q30239985-40865F44-E4BB-4967-A9B3-A55505395203Q30244553-35890BD1-F9D8-405A-8258-BEBB5484F586Q30650570-2F434442-EC4E-4ABD-9108-C9BCF01F94D1Q30884958-06BF79D9-C31B-4593-AFBD-E4AF69F4AA13Q33634184-17128594-9E47-4291-87D1-BF69796B9DB7Q33746059-686DDF00-CECA-4D73-A7DA-A9615AE67779Q33783663-5731B936-6EC0-4AFB-869E-EE5D5F803CCAQ33889309-47E85B4C-40AA-4638-8305-B01551CA40EAQ34137936-890FF734-D0BF-49E3-8572-6B402E672BECQ34154516-983003C7-CFAB-444C-BDB6-27EB758F280FQ34455355-719AAE69-AAB8-47D3-98BB-E45B2583AC3CQ34516083-04D6313B-9B41-4196-A241-D23733B839FBQ34729026-C8483682-2ECF-4C02-909A-C7C01BCE696BQ35022833-6F4A1EE8-83B9-4564-8705-66BDCCDE45B3Q35105819-2F8EBCA8-AA26-4526-B41D-C510525B523BQ35114800-0A816EAE-33B3-472C-BA21-A8B659A91D80Q35186682-0AE8DF1B-10E9-4B5B-81DC-9F54EF6632D0Q35240656-03F40BBA-AAAD-4D93-98E8-1B2EAA8D5A89Q35689166-FDA188F9-7D73-417A-AB86-8779E5C0A113Q35750752-4932210D-2C5E-400D-A3B1-8DE53438192DQ35825986-11591D54-BA11-4BD1-BFC5-E4A785FA1461Q35835628-3E9FEF19-9C1D-4D73-A1DB-0CAE8AA9C03FQ35890561-9B3A0D15-255C-4197-A0C8-F2DA1EE046A7Q36080974-32808A90-028B-4A4C-96AC-7643E69FF931Q36116337-42B17E87-96BC-4924-8790-683F25087B1AQ36161365-8E6CBC8D-C51F-4074-9219-BCA1A87EAADCQ36172858-DF349D34-D0A8-46D1-8B85-BC8441EA7975Q36205400-FA1D993C-6BB9-4551-85C0-B1F25040DE37Q36239776-14C11684-7A52-4240-8398-27A91E5CBF74Q36330634-CC748E90-C989-41D9-B238-721A928BD3E1Q36417250-AC969726-8398-4798-941E-319029B8771FQ36470196-D5E4E7DF-7DB8-4C05-9468-6D5F25158C9DQ36793430-BB5CDFDE-229F-4728-83BD-B379CA0493F2Q36865042-A0597608-60D0-47B9-A0E6-1CCC74EAB0DF
P2860
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cutaneous lymphoma incidence p ...... ion-based study of 3884 cases.
@en
Cutaneous lymphoma incidence p ...... ion-based study of 3884 cases.
@nl
type
label
Cutaneous lymphoma incidence p ...... ion-based study of 3884 cases.
@en
Cutaneous lymphoma incidence p ...... ion-based study of 3884 cases.
@nl
prefLabel
Cutaneous lymphoma incidence p ...... ion-based study of 3884 cases.
@en
Cutaneous lymphoma incidence p ...... ion-based study of 3884 cases.
@nl
P2093
P2860
P1433
P1476
Cutaneous lymphoma incidence p ...... ion-based study of 3884 cases.
@en
P2093
Jorge R Toro
Porcia T Bradford
William F Anderson
P2860
P304
P356
10.1182/BLOOD-2008-10-184168
P407
P577
2009-03-11T00:00:00Z